Skip to main content


International Journal of Clinical Oncology

International Journal of Clinical Oncology OnlineFirst articles

18.02.2019 | Original Article

Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety

The development of molecular-targeted drugs has been progressing recently all around the world, providing clinicians with several options now in the treatment of colorectal cancer (CRC) [ 1 ]. By considering the gene mutation profile or site of the …

15.02.2019 | Original Article

Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer

Epithelial ovarian carcinoma (EOC) is one of the leading causes of cancer-related mortality among women with gynecological malignancies [ 1 ]. Since EOC often remains silent in clinical practice, the majority of patients display aggressive …

13.02.2019 | Original Article

Adjuvant therapy in renal cell carcinoma: the perspective of urologists

The incidence of renal cell cancer (RCC) is rising to 15.9 per 100,000 men and women per year. RCC has a mortality of 3.8 per 100,000 patients per year [ 1 ]. RCC is mostly diagnosed incidentally within the framework of imaging because of other …

12.02.2019 | Original Article

Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience

Endometrial cancer (EC) is one of the most common gynecological malignancies. The incidence has gradually increased in decades [ 1 , 2 ]. About 25% of the patients are diagnosed in premenopausal women and 5–7% patients are younger than 40 [ 3 , 4 …

12.02.2019 | Original Article

Saddle pulmonary embolism and in-hospital mortality in patients with cancer

Patients with cancer are at a substantially higher risk of venous thromboembolism when compared to patients without cancer due to treatment (e.g., surgical interventions and chemotherapy) and disease related (e.g., hypercoagulable state) factors [ …

Aktuelle Ausgaben

Über diese Zeitschrift

The International Journal of Clinical Oncology (IJCO) welcomes original research papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Experimental studies will also be accepted if they have obvious relevance to clinical oncology. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that: their contents have not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.

Weitere Informationen


Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.